Hide Board Information

Show Board Information

NextPlat Corp. NXPL

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/06/2025 3:42:46 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 88

NextPlat Corp. (NASDAQ: NXPL) Stock Message Board

1. NXPL Company Profile

    

2. NXPL Time & Sales

    

3. NXPL Recent News

    

4. NXPL Filings

    

5. NXPL Financials

    

6. NXPL Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	Amazons $5 Monthly Plan to Deepen Giants	NetworkNewsWire	05/30/2023 4:48:40 PM
7	NextPlat Corp. (NASDAQ: NXPL) Celebrates Great	NetworkNewsWire	05/26/2023 3:50:01 PM
6	NextPlat Corp. (NASDAQ: NXPL) Inks Deal to Open	NetworkNewsWire	05/24/2023 4:23:56 PM
5	Five Trends Shaping Healthcare e-Commerce	NetworkNewsWire	05/23/2023 6:11:41 PM
4	NetworkNewsBreaks Why NextPlat Corp. (NASDAQ:	NetworkNewsWire	05/22/2023 4:05:38 PM
3	NetworkNewsBreaks NextPlat Corp. (NASDAQ:	NetworkNewsWire	05/11/2023 3:50:02 PM
2	NextPlat Corp. (NASDAQ: NXPL) Is One to	NetworkNewsWire	05/10/2023 3:32:19 PM
1	$NXPL 63% v1,0M Hod4.26 f17,869M NextPlat Corp.	znewcar1	04/24/2023 9:39:19 AM

Newer

Recent Articles

• Exploring VOSK's Top Artisan Candle Designs from Customers
• Downtown Hackensack Unveils New Sculptures to Inspire Community
• Exploring the Growth and Future of Carbon Nanotubes Market
• Traction Uranium Welcomes Paul Sparkes to Leadership Team
• Traction Uranium Corp. Welcomes Paul Sparkes to Board
• Neogen Corporation Investors Invited to Join Class Action Claims
• Investors Should Know About Hims & Hers Health Legal Actions
• Unraveling the Secrets of AI: Rose G Loops’ Insightful Journey
• Discover the Growth of $100 in Exxon Mobil Over 5 Years
• Freeman Gold Secures Financing to Advance Lemhi Gold Project
• Soma Gold Corp. Successfully Secures $15.5 Million Funding
• Unleashing Victory: Mitch Guthrie Jr. Triumphs at Vegas to Reno
• RemeGen Collaborates with Santen for Revolutionary Eye Drug
• Key Insights for Vera Bradley, Inc. Investors on Class Action
• KBR, Inc. Shares Face Investigation Amid Allegations of Misleading Info
• Join the Excitement at the Salsa Social Dance in Hackensack
• Sienna Senior Living Secures $175 Million in Debenture Offering
• A Profitable Journey: Cigna Group's Growth Over 15 Years
• Examining the Executive Authority in CPSC Dismissals
• CSL Reports Impressive Growth and Strategic Transformation Plans
• MAG Silver Corp. Announces Key Election Information on Share Arrangement
• Purpose Investments Reveals New Funds Distribution Plans
• TeraWulf Boosts Capital with $850 Million Convertible Notes Deal
• iRobot Investors: Claim Your Rights by Upcoming Deadline
• Transforming $100 Into $323: The Nutanix Story of Growth
• Stock Insights as the Market Evolves: Palantir's Leap
• HCA Healthcare: A Journey of $1000 Investment Over a Decade
• CSL's Strategic Growth and Transformation Plans for Future
• Blazing Star Merger's Tender Offer Update for Walgreens Notes
• Joolz Launches Aer2 Stroller: A Perfect Solution for Parents
• AccountabilIT Joins MISA to Enhance Cybersecurity Solutions
• Sienna Senior Living Strengthens Position with New Debenture Offering
• TeraWulf Inc. Expands Bitcoin Mining with $850 Million Funding
• Flow Capital Completes Early Repayment of Sleep Wellness Investment
• Fabrinet's Strong Q4 FY2025 Results and Future Growth Strategies
• True Global Ventures Expands Horizons with New CMS Licence
• Whirlpool Corporation Announces Quarterly Dividend Payment
• CSL's Strategic Plans for Growth and Shareholder Value
• Lyno AI's Early Bird Presale Sees Remarkable Token Sales
• Opthea's Significant Corporate Developments and Further Actions
• LEEF Brands Successfully Closes CAD $2.09 Million Placement
• Investors Urged to Participate in Charter Communications Class Action
• Investors Unite: Class Action Against Altimmune, Inc. Launched
• Exploring Legal Rights for Ibotta, Inc. Shareholders
• LEEF Brands Secures CAD 2.09 Million Through Successful Financing
• Exciting Product Launches Ahead for Apple Inc. in 2025
• Whirlpool Corporation Adds Mary Ellen Adcock to Board
• Understanding the Altimmune, Inc. Stockholder Rights and Legality
• Navigate Legal Proceedings with Capricor Therapeutics' Investors
• Opportunity for CTO Investors Amid Class Action Securities Case